Loading data for LMMY — first visit, this takes a few seconds.
Exousia Bio, Inc.（LMMY）の株価・分析・データ
本質的価値
アナリスト予想
株価予想 →最新決算
| 実績 | 予想との差 | 前年比 | |
|---|---|---|---|
| 売上高 | — | n/a | n/a |
| EPS（TTM） | — | n/a | n/a |
事業指標
Exousia Bio, Inc.について
企業情報を見る →Exousia Bio, Inc., a biotechnology company, designs, develops, and manufactures mammalian- and plant-derived exosomes using proprietary technologies for nucleic acid loading and targeted delivery to tissues and cells. The company's platform enables the custom production of exosomes with enhanced genetic functionality that can selectively target specific cells to address diseases. The company was formerly known as LAMY and changed its name to Exousia Bio, Inc. in January 2026. The company was incorporated in 2022 and is based in Saint Petersburg, Florida.
Exousia Bio, Inc., a biotechnology company, designs, develops, and manufactures mammalian- and plant-derived exosomes using proprietary technologies for nucleic acid loading and targeted delivery to tissues and cells. The company's platform enables the custom production of exosomes with enhanced genetic functionality that can selectively target specific cells to address diseases. The company was formerly known as LAMY and changed its name to Exousia Bio, Inc. in January 2026. The company was incorporated in 2022 and is based in Saint Petersburg, Florida.
セクター Consumer Defensive
IPO日 Oct 1, 2024
従業員数 n/a
上場取引所 OTC Markets OTCPK
ティッカー LMMY
ウェブサイト https://exousiabio.com